Live
- Why didn't Kejriwal appear on summons: SC
- Final chance for Indian wrestlers to qualify for Paris Olympics 2024
- IPL 2024 LSG vs MI: Mayank Yadav recovers from injury, set to play against Mumbai
- Battleground Bengal: Third phase most critical for ECI on security issues
- TN fishermen attacked mid-sea, robbed by pirates
- BJP accused of having soft corner for Prajwal Revanna’s ‘sexploits’
- BJP says ‘Jai Shri Ram’ as it did nothing for people: KTR
- CM losing people’s trust: BRS leader
- KTR trying to inflame passions: Cong leader
- BRS stares at big exodus of civic body leaders across TS
SPC Lifesciences files papers for `300-cr IPO
Pharmaceutical ingredients maker SPC Lifesciences Ltd has filed preliminary papers with the capital market regulator Sebi to raise funds through an initial public offering.
New Delhi: Pharmaceutical ingredients maker SPC Lifesciences Ltd has filed preliminary papers with the capital market regulator Sebi to raise funds through an initial public offering. The Initial Public Offering (IPO) consists of fresh issuance of equity shares worth Rs 300 crore and an Offer For Sale (OFS) of 89.39 lakh equity shares by promoter - SnehalRajivbhai Patel, according to the draft red herring prospectus. The company may consider a pre-IPO placement aggregating up to Rs 60 crore and if such a placement is completed, then the fresh issue size will be reduced. The proceeds from the fresh issue will be used to pay debt, to support working capital needs and to fund capital expenditure requirements for setting up Phase-2 at its Dahej facility in order to expand product offerings of pharmaceutical intermediates, and for general corporate purpose. Gujarat-based SPC Lifesciences is a leading manufacturer of advanced intermediates for certain key active pharmaceutical ingredients.
